Sort
15,842 grants matching “pancreatic cancer”
Survival Mechanisms of Invasive Carcinoma Cells
$351,599Richard L. Klemke · University Of California, San Diego · R01 · FY2017 · CA
Palmitoylation of Hedgehog Proteins
$351,560Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2009 · GM
Palmitoylation of Hedgehog Proteins
$351,560Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2008 · GM
Characterization of lcmt in Animal Models of Cancer
$351,539Mark Reid Philips · New York University School Of Medicine · R01 · FY2012 · CA
Project 1: Targeting Metabolic Dependencies in PDAC
$351,368Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
New Triterpenoids for Chemoprevention and Therapy of Cancer
$351,366Michael B Sporn · Dartmouth College · R01 · FY2009 · CA
New Triterpenoids for Chemoprevention and Therapy of Cancer
$351,366Michael B Sporn · Dartmouth College · R01 · FY2010 · CA
Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus
$351,363Xiaoliu Zhang · University Of Houston · R01 · FY2015 · CA
TOR signaling and autophagy in obesity-promoted liver tumorigenesis
$351,277Michael Karin · University Of California, San Diego · R01 · FY2015 · CA
Role of Glypican-1 in Pancreatic Cancer
$351,244Dartmouth College · R01 · FY2004 · CA
Functional Characterization of CCDC130 Gene
$351,200Deepak Kumar · University Of The District Of Columbia · SC1 · FY2009 · CA
Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC
$351,132Masato Yamamoto · University Of Minnesota · R01 · FY2018 · CA
Disrupting MDSC-fibroblast interactions to overcome chemoimmunotherapy resistance in pancreatic cancer
$351,131Jashodeep Datta · University Of Miami School Of Medicine · R37 · FY2024 · CA
UPR Activators for Cancer Therapy
$351,131Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2025 · CA
Disrupting MDSC-fibroblast interactions to overcome chemoimmunotherapy resistance in pancreatic cancer
$351,131Jashodeep Datta · University Of Miami School Of Medicine · R37 · FY2025 · CA
Common genetically altered pathways as targets for therapy in pancreatic cancer
$351,131Agnieszka Witkiewicz · University Of Arizona · R01 · FY2017 · CA
The Evolution of PGD Addiction in Human Pancreatic Cancer
$351,131Oliver Gene McDonald · University Of Miami School Of Medicine · R01 · FY2025 · CA
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
$351,112Laurence H Hurley · University Of Arizona · R01 · FY2012 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
$351,098David C Linehan · University Of Rochester · R01 · FY2020 · CA
Project 1: Targeting Metabolic Dependencies in PDAC
$351,015Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA
Development of a first-in-class mEGFR dimerization inhibitor
$351,000Mukesh K. Nyati · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Identifying Molecular Drivers of Cellular Plasticity in Pancreatic Cancer
$350,960Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2024 · CA
Dissecting new mechanisms of lysosome quality control in health and disease
$350,960Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2024 · CA
SLC6A14 as a unique drug target to treat pancreatic cancer
$350,851Yangzom Doma Bhutia · Texas Tech University Health Scis Center · R01 · FY2025 · CA
Role of ICAM1 in development and progression of pancreatic cancer
$350,834Peter Storz · Mayo Clinic Jacksonville · R01 · FY2022 · CA